<code id='10F069248D'></code><style id='10F069248D'></style>
    • <acronym id='10F069248D'></acronym>
      <center id='10F069248D'><center id='10F069248D'><tfoot id='10F069248D'></tfoot></center><abbr id='10F069248D'><dir id='10F069248D'><tfoot id='10F069248D'></tfoot><noframes id='10F069248D'>

    • <optgroup id='10F069248D'><strike id='10F069248D'><sup id='10F069248D'></sup></strike><code id='10F069248D'></code></optgroup>
        1. <b id='10F069248D'><label id='10F069248D'><select id='10F069248D'><dt id='10F069248D'><span id='10F069248D'></span></dt></select></label></b><u id='10F069248D'></u>
          <i id='10F069248D'><strike id='10F069248D'><tt id='10F069248D'><pre id='10F069248D'></pre></tt></strike></i>

          Home / hotspot / leisure time

          leisure time


          leisure time

          author:entertainment    Page View:89
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In